Literature DB >> 2687768

Nucleotide sequence analysis of human abl and bcr-abl cDNAs.

E Fainstein1, M Einat, E Gokkel, C Marcelle, C M Croce, R P Gale, E Canaani.   

Abstract

The complete nucleotide sequence of human abl RNA containing exon Ia was determined. It spans 5598 nucleotides and codes for a protein of 1130 amino acids. The 3' untranslated region contains two short open reading frames and multiple ATTT(A) motifs characteristic of short lived mRNAs. Computer analysis of the abl protein predicts four domains distinct with regard to surface probability and chain flexibility. Nucleotide analysis of the abl segment within a bcr-abl cDNA cloned from the K562 cell line indicated no further alterations within the coding region. A bcr-abl construct containing this segment transformed, together with c-myc, RAT-1 cells and produced a highly active tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2687768

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  DNA repair protein O6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct and novel protein kinases in human brain tumour cells.

Authors:  S R Mullapudi; F Ali-Osman; J Shou; K S Srivenugopal
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.

Authors:  J R McWhirter; J Y Wang
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

3.  Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.

Authors:  S K Shore; S L Bogart; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.

Authors:  Rathi N Pillai; Lisa S Chen; Mary L Ayres; Billie J Nowak; Michael W Thomas; Elizabeth J Shpall; Michael J Keating; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2012-04-23

5.  p53 in chronic myelogenous leukemia in acute phase.

Authors:  E Feinstein; G Cimino; R P Gale; G Alimena; R Berthier; K Kishi; J Goldman; A Zaccaria; A Berrebi; E Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

6.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

Authors:  A J Muller; J C Young; A M Pendergast; M Pondel; N R Landau; D R Littman; O N Witte
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

7.  Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.

Authors:  M Wetzler; M Talpaz; R A Van Etten; C Hirsh-Ginsberg; M Beran; R Kurzrock
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testes.

Authors:  C Hall; W C Sin; M Teo; G J Michael; P Smith; J M Dong; H H Lim; E Manser; N K Spurr; T A Jones
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

9.  Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation.

Authors:  N N Danial; J A Losman; T Lu; N Yip; K Krishnan; J Krolewski; S P Goff; J Y Wang; P B Rothman
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

10.  Induction of protein-tyrosine-phosphatase activity by interleukin 6 in M1 myeloblastic cells and analysis of possible counteractions by the BCR-ABL oncogene.

Authors:  D Zafriri; M Argaman; E Canaani; A Kimchi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.